Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Domiphen Bromide
2. Domiphen Chloride
3. Domiphen Hydroxide
1. Phenododecinium
2. Domiphen Cation
3. Domiphen Ion
4. 13900-14-6
5. Dodecyl-dimethyl-(2-phenoxyethyl)azanium
6. 4azl56cu0f
7. Dodecyldimethyl(2-phenoxyethyl)ammonium
8. 1-dodecanaminium, N,n-dimethyl-n-(2-phenoxyethyl)
9. Ncgc00091010-03
10. Unii-4azl56cu0f
11. Domiphen [vandf]
12. Domiphen [who-dd]
13. Schembl1702653
14. Chembl1187011
15. Dtxsid2048080
16. Yxupzgkorwtxid-uhfffaoysa-
17. Chebi:135978
18. Zinc6845992
19. Stl257462
20. Akos022105914
21. Db11594
22. (beta-phenoxyethyl)dimethyldodecylammonium
23. Ncgc00091010-02
24. Ncgc00091010-04
25. Ncgc00091010-05
26. Dodecyl-dimethyl-(2-phenoxyethyl)ammonium
27. Ab01566921_01
28. Dodecyl-dimethyl-(2-phenoxyethyl)azanium Bromide
29. N,n-dimethyl-n-(2-phenoxyethyl)dodecan-1-aminium
30. (.beta.-phenoxyethyl)dimethyldodecylammonium
31. Q27098012
| Molecular Weight | 334.6 g/mol |
|---|---|
| Molecular Formula | C22H40NO+ |
| XLogP3 | 7.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 15 |
| Exact Mass | 334.310989899 g/mol |
| Monoisotopic Mass | 334.310989899 g/mol |
| Topological Polar Surface Area | 9.2 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 1 |
| Complexity | 271 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-infective (topical), it is used for the treatment of Acute Infectious Dental Diseases and other conditions.
The efficacy and tolerability of domiphen bromide (domifen bromide), administered at a dosage of 0.5 mg every 4-6 hr in a double-blind placebo controlled study in 31 patients affected by acute infectious dental diseases, are described. After 2 days of treatment with the drug, there was a significant decrease in pain and inflammation. The drug elicited a good response, improved prognosis and reduced the number of days of illness.
A - Alimentary tract and metabolism
A01 - Stomatological preparations
A01A - Stomatological preparations
A01AB - Antiinfectives and antiseptics for local oral treatment
A01AB06 - Domiphen
Domiphen bromide is a quaternary antiseptic with actions and uses similar to those of cationic surfactants.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
